|
STK35 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.57270000000764E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.958000E-04 |
| Normal-vs-Stage2 |
4.001800E-02 |
| Normal-vs-Stage3 |
8.341800E-03 |
| Normal-vs-Stage4 |
1.814630E-01 |
| Stage1-vs-Stage2 |
5.030200E-01 |
| Stage1-vs-Stage3 |
2.276200E-01 |
| Stage1-vs-Stage4 |
5.895400E-01 |
| Stage2-vs-Stage3 |
6.620800E-01 |
| Stage2-vs-Stage4 |
2.894600E-01 |
| Stage3-vs-Stage4 |
1.169650E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.5128399999953E-05 |
| Normal-vs-AfricanAmerican |
5.004000E-03 |
| Normal-vs-Asian |
9.158800E-01 |
| Caucasian-vs-AfricanAmerican |
3.746400E-01 |
| Caucasian-vs-Asian |
2.968400E-01 |
| AfricanAmerican-vs-Asian |
3.592400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.79100000000144E-05 |
| Normal-vs-Female |
1.92042999999087E-05 |
| Male-vs-Female |
5.975600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.167900E-02 |
| Normal-vs-Extreme_Weight |
1.784450E-02 |
| Normal-vs-Obese |
2.42999999999771E-05 |
| Normal-vs-Extreme_Obese |
1.337360E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.963800E-01 |
| Normal_Weight-vs-Obese |
8.690000E-02 |
| Normal_Weight-vs-Extreme_Obese |
9.635200E-01 |
| Extreme_Weight-vs-Obese |
1.965630E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.421000E-01 |
| Obese-vs-Extreme_Obese |
3.390400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.603770E-03 |
| Normal-vs-Age(41-60Yrs) |
1.99769999986721E-07 |
| Normal-vs-Age(61-80Yrs) |
5.318500E-03 |
| Normal-vs-Age(81-100Yrs) |
1.795000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.827800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.324200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.202200E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.197200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.67669999999931E-05 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.923200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.43980000000266E-06 |
| Normal-VS-Type2 PRCC |
6.963600E-01 |
| Normal-VS-KIRP CIMP |
3.360400E-03 |
| Normal-VS-Unclassified PRCC |
5.90109999999422E-05 |
| Type1 PRCC-VS-Type2 PRCC |
5.90699999999389E-05 |
| Type1 PRCC-VS-KIRP CIMP |
6.581700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.719500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.86020000000942E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
1.559400E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
5.480600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.984400E-02 |
| Normal-vs-N1 |
1.143410E-03 |
| Normal-vs-N2 |
1.019670E-02 |
| N0-vs-N1 |
4.423700E-02 |
| N0-vs-N2 |
4.959600E-01 |
| N1-vs-N2 |
7.554800E-01 |
|
|
